Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Non-Current Liabilities (2016 - 2022)

Tenax Therapeutics' Total Non-Current Liabilities history spans 6 years, with the latest figure at $975167.0 for Q4 2017.

  • On a quarterly basis, Total Non-Current Liabilities fell 84.13% to $975167.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $975167.0, a 84.13% decrease, with the full-year FY2017 number at $975167.0, down 84.13% from a year prior.
  • Total Non-Current Liabilities hit $975167.0 in Q4 2017 for Tenax Therapeutics, up from $802474.0 in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for TENX hit a ceiling of $12.9 million in Q2 2016 and a floor of -$82.8 million in Q2 2014.
  • Historically, Total Non-Current Liabilities has averaged -$5.6 million across 5 years, with a median of $975167.0 in 2017.
  • Biggest five-year swings in Total Non-Current Liabilities: crashed 1770.23% in 2014 and later surged 1799.17% in 2017.
  • Tracing TENX's Total Non-Current Liabilities over 5 years: stood at $5.0 million in 2013, then tumbled by 114.45% to -$716759.0 in 2014, then surged by 1779.7% to $12.0 million in 2015, then tumbled by 48.98% to $6.1 million in 2016, then plummeted by 84.13% to $975167.0 in 2017.
  • Business Quant data shows Total Non-Current Liabilities for TENX at $975167.0 in Q4 2017, $802474.0 in Q3 2017, and $2.1 million in Q2 2017.